From the Editors' Desk

Another Recall Over Potential Sterility Concerns

FDA concerns about aseptic and GMP practices at a manufacturer's site "potentially impacting product sterility" has prompted another recall this week.

Noxilizer RTS Series NO2 Sterilizers Earn CE Mark

Noxilizer Inc. reports that it has been approved for the CE marking of its RTS Series Sterilizers under the Medical Device Directive (MDD). The RTS series use room-temperature NO2 technology in a "rapid process that offers manufacturers...

Time to Apply for Packaging Scholarships

The Institute of Packaging Professionals (IoPP) is announcing the availability of six academic scholarships to students interested in packaging. According to IoPP's Web site, support...

Clear Code adds contrast to traditional coding

3C! Packaging will premiere a sophisticated new coating for coding applications at INTERPHEX NYC 2015, April 21-23 at the Jacob K. Javits Center.  Offering high precision, functionality and consistency...

Great Expectations for Cost-Cutting U.S. Biosimilars but There is a Catch

The imminent approval of the first biosimilars in the U.S. brings widespread optimism that they will stem the tide of soaring specialty drug costs. While biosimilars will yield savings, a new report sponsored by Prime Therapeutics (Prime) cautions...

Multi Packaging Solutions Commits to 3D Printing Technology

Multi Packaging Solutions (MPS), a global provider of value-added print and packaging solutions for the branded, healthcare, and multimedia markets, has invested in the latest 3D printing technology for creating plastic prototypes.

...
E-Health Driving Changes in Drug Delivery

Compatibility with e-health initiatives will be a big differentiator for pharmaceutical companies in the future, argues Mike Schäfers, VP Global Marketing PPS, West Pharmaceutical Services LLC. West recently exhibited at Pharmapack Europe.

Recall Issued Because of Potential Impact to Sterility

Concerns about aseptic and GMP practices potentially impacting product sterility has prompted a voluntary recall.

Turing Pharmaceuticals Launches to Tackle Diseases Currently with Limited Treatment Options

Launching this week is Turing Pharmaceuticals AG, a new company setting out to develop and commercialize treatments for serious diseases and conditions "for which there are currently limited or no treatment options," the company reports in a...